This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Brainsway® is excited to announce that Transcranial Magnetic Stimulation is now available to Blue Cross Blue Shield North Carolina clients. Coverage for Brainsway’s TMS treatment is being reviewed by BCBS NC’s behavioral health vendors: Magellan and/or Value Options. Blue Cross Blue Shield North Carolina serves 3.9 Million patients.